GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmesis International Ltd (SGX:BFK) » Definitions » PB Ratio

Pharmesis International (SGX:BFK) PB Ratio : 0.23 (As of May. 29, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Pharmesis International PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-29), Pharmesis International's share price is S$0.08. Pharmesis International's Book Value per Share for the quarter that ended in Dec. 2023 was S$0.35. Hence, Pharmesis International's PB Ratio of today is 0.23.

The historical rank and industry rank for Pharmesis International's PB Ratio or its related term are showing as below:

SGX:BFK' s PB Ratio Range Over the Past 10 Years
Min: 0.15   Med: 0.36   Max: 0.73
Current: 0.23

During the past 13 years, Pharmesis International's highest PB Ratio was 0.73. The lowest was 0.15. And the median was 0.36.

SGX:BFK's PB Ratio is ranked better than
98.11% of 954 companies
in the Drug Manufacturers industry
Industry Median: 1.97 vs SGX:BFK: 0.23

During the past 12 months, Pharmesis International's average Book Value Per Share Growth Rate was -24.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -11.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -11.90% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -9.50% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Pharmesis International was 5.30% per year. The lowest was -14.20% per year. And the median was -5.10% per year.

Back to Basics: PB Ratio


Pharmesis International PB Ratio Historical Data

The historical data trend for Pharmesis International's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmesis International PB Ratio Chart

Pharmesis International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.42 0.57 0.28 0.24 0.28

Pharmesis International Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.19 0.24 0.39 0.28

Competitive Comparison of Pharmesis International's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmesis International's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmesis International's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmesis International's PB Ratio distribution charts can be found below:

* The bar in red indicates where Pharmesis International's PB Ratio falls into.



Pharmesis International PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Pharmesis International's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.08/0.345
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Pharmesis International  (SGX:BFK) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Pharmesis International PB Ratio Related Terms

Thank you for viewing the detailed overview of Pharmesis International's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmesis International (SGX:BFK) Business Description

Traded in Other Exchanges
N/A
Address
5 Kallang Sector, No. 03-02, Singapore, SGP, 349279
Pharmesis International Ltd is an investment holding company. The company manufactures pharmaceutical products in the form of tablets, granules, pills, and other forms. Its geographical segments are Western drugs, which are chemically formulated drugs and are marketed under the Kinna brand; TCM formulated drugs, which refer to Traditional Chinese Medicine and are marketed under the Longlife brand; and Distribution. The company derives revenue from the sale of medicines to domestic customers in China.

Pharmesis International (SGX:BFK) Headlines